Table 5.
cGVHD scoring according to National Institutes of Health consensus criteria: individual organ severity and global severity score
| Evaluable patients no. (%) |
|
|---|---|
| Skin | |
| 0 | 30 (85.7) |
| 1 | 2 (5.7) |
| 2 | 3 (8.6) |
| 3 | 0 (0.0) |
| Mouth | |
| 0 | 32 (91.4) |
| 1 | 2 (5.7) |
| 2 | 1 (2.9) |
| 3 | 0 (0.0) |
| Eye | |
| 0 | 30 (85.7) |
| 1 | 4 (11.4) |
| 2 | 1 (2.9) |
| 3 | 0 (0.0) |
| Lung | |
| 0 | 33 (94.3) |
| 1 | 1 (2.9) |
| 2 | 1 (2.9) |
| 3 | 0 (0.0) |
| Gastrointestinal | |
| 0 | 33 (94.3) |
| 1 | 2 (5.7) |
| 2 | 0 (0.0) |
| 3 | 0 (0.0) |
| Liver | |
| 0 | 28 (80.0) |
| 1 | 5 (14.3) |
| 2 | 1 (2.9) |
| 3 | 1 (2.9) |
| Genital | |
| 0 | 35 (100.0) |
| 1 | 0 (0.0) |
| 2 | 0 (0.0) |
| 3 | 0 (0.0) |
| Joint/fascia | |
| 0 | 32 (91.4) |
| 1 | 3 (8.6) |
| 2 | 0 (0.0) |
| 3 | 0 (0.0) |
| Overall grade | |
| 0 | 23 (65.7) |
| 1 | 6 (17.1) |
| 2 | 4 (11.4) |
| 3 | 2 (5.7) |